img

Global Paclitaxel Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Paclitaxel Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
Paclitaxel Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Paclitaxel Drug market is projected to reach US$ 139.3 million in 2029, increasing from US$ 117.6 million in 2022, with the CAGR of 2.4% during the period of 2024 to 2029. Demand from Hospital and Drugs Store are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Paclitaxel Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Luye Pharma
CSPC Company
Celgene
Jiangsu Hengrui
Bristol-Myers Squibb
Pfizer
Teva
Mylan
Novartis
Segment by Type
30mg
100mg

Segment by Application


Hospital
Drugs Store

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Paclitaxel Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Paclitaxel Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Paclitaxel Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Paclitaxel Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Paclitaxel Drug introduction, etc. Paclitaxel Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Paclitaxel Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Paclitaxel Drug Market Overview
1.1 Paclitaxel Drug Product Overview
1.2 Paclitaxel Drug Market Segment by Type
1.2.1 30mg
1.2.2 100mg
1.3 Global Paclitaxel Drug Market Size by Type
1.3.1 Global Paclitaxel Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Paclitaxel Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Paclitaxel Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Paclitaxel Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Paclitaxel Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Paclitaxel Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Paclitaxel Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Paclitaxel Drug Sales Breakdown by Type (2018-2024)
2 Global Paclitaxel Drug Market Competition by Company
2.1 Global Top Players by Paclitaxel Drug Sales (2018-2024)
2.2 Global Top Players by Paclitaxel Drug Revenue (2018-2024)
2.3 Global Top Players by Paclitaxel Drug Price (2018-2024)
2.4 Global Top Manufacturers Paclitaxel Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Paclitaxel Drug Market Competitive Situation and Trends
2.5.1 Paclitaxel Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Paclitaxel Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Paclitaxel Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Paclitaxel Drug Market
2.8 Key Manufacturers Paclitaxel Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Paclitaxel Drug Status and Outlook by Region
3.1 Global Paclitaxel Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Paclitaxel Drug Historic Market Size by Region
3.2.1 Global Paclitaxel Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Paclitaxel Drug Sales in Value by Region (2018-2024)
3.2.3 Global Paclitaxel Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Paclitaxel Drug Forecasted Market Size by Region
3.3.1 Global Paclitaxel Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Paclitaxel Drug Sales in Value by Region (2024-2029)
3.3.3 Global Paclitaxel Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Paclitaxel Drug by Application
4.1 Paclitaxel Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Drugs Store
4.2 Global Paclitaxel Drug Market Size by Application
4.2.1 Global Paclitaxel Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Paclitaxel Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Paclitaxel Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Paclitaxel Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Paclitaxel Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Paclitaxel Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Paclitaxel Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Paclitaxel Drug Sales Breakdown by Application (2018-2024)
5 North America Paclitaxel Drug by Country
5.1 North America Paclitaxel Drug Historic Market Size by Country
5.1.1 North America Paclitaxel Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Paclitaxel Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Paclitaxel Drug Sales in Value by Country (2018-2024)
5.2 North America Paclitaxel Drug Forecasted Market Size by Country
5.2.1 North America Paclitaxel Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Paclitaxel Drug Sales in Value by Country (2024-2029)
6 Europe Paclitaxel Drug by Country
6.1 Europe Paclitaxel Drug Historic Market Size by Country
6.1.1 Europe Paclitaxel Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Paclitaxel Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Paclitaxel Drug Sales in Value by Country (2018-2024)
6.2 Europe Paclitaxel Drug Forecasted Market Size by Country
6.2.1 Europe Paclitaxel Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Paclitaxel Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Paclitaxel Drug by Region
7.1 Asia-Pacific Paclitaxel Drug Historic Market Size by Region
7.1.1 Asia-Pacific Paclitaxel Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Paclitaxel Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Paclitaxel Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Paclitaxel Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Paclitaxel Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Paclitaxel Drug Sales in Value by Region (2024-2029)
8 Latin America Paclitaxel Drug by Country
8.1 Latin America Paclitaxel Drug Historic Market Size by Country
8.1.1 Latin America Paclitaxel Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Paclitaxel Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Paclitaxel Drug Sales in Value by Country (2018-2024)
8.2 Latin America Paclitaxel Drug Forecasted Market Size by Country
8.2.1 Latin America Paclitaxel Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Paclitaxel Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Paclitaxel Drug by Country
9.1 Middle East and Africa Paclitaxel Drug Historic Market Size by Country
9.1.1 Middle East and Africa Paclitaxel Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Paclitaxel Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Paclitaxel Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Paclitaxel Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Paclitaxel Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Paclitaxel Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Luye Pharma
10.1.1 Luye Pharma Company Information
10.1.2 Luye Pharma Introduction and Business Overview
10.1.3 Luye Pharma Paclitaxel Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Luye Pharma Paclitaxel Drug Products Offered
10.1.5 Luye Pharma Recent Development
10.2 CSPC Company
10.2.1 CSPC Company Company Information
10.2.2 CSPC Company Introduction and Business Overview
10.2.3 CSPC Company Paclitaxel Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 CSPC Company Paclitaxel Drug Products Offered
10.2.5 CSPC Company Recent Development
10.3 Celgene
10.3.1 Celgene Company Information
10.3.2 Celgene Introduction and Business Overview
10.3.3 Celgene Paclitaxel Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Celgene Paclitaxel Drug Products Offered
10.3.5 Celgene Recent Development
10.4 Jiangsu Hengrui
10.4.1 Jiangsu Hengrui Company Information
10.4.2 Jiangsu Hengrui Introduction and Business Overview
10.4.3 Jiangsu Hengrui Paclitaxel Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Jiangsu Hengrui Paclitaxel Drug Products Offered
10.4.5 Jiangsu Hengrui Recent Development
10.5 Bristol-Myers Squibb
10.5.1 Bristol-Myers Squibb Company Information
10.5.2 Bristol-Myers Squibb Introduction and Business Overview
10.5.3 Bristol-Myers Squibb Paclitaxel Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Bristol-Myers Squibb Paclitaxel Drug Products Offered
10.5.5 Bristol-Myers Squibb Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Information
10.6.2 Pfizer Introduction and Business Overview
10.6.3 Pfizer Paclitaxel Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Pfizer Paclitaxel Drug Products Offered
10.6.5 Pfizer Recent Development
10.7 Teva
10.7.1 Teva Company Information
10.7.2 Teva Introduction and Business Overview
10.7.3 Teva Paclitaxel Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Teva Paclitaxel Drug Products Offered
10.7.5 Teva Recent Development
10.8 Mylan
10.8.1 Mylan Company Information
10.8.2 Mylan Introduction and Business Overview
10.8.3 Mylan Paclitaxel Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Mylan Paclitaxel Drug Products Offered
10.8.5 Mylan Recent Development
10.9 Novartis
10.9.1 Novartis Company Information
10.9.2 Novartis Introduction and Business Overview
10.9.3 Novartis Paclitaxel Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Novartis Paclitaxel Drug Products Offered
10.9.5 Novartis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Paclitaxel Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Paclitaxel Drug Industrial Chain Analysis
11.4 Paclitaxel Drug Market Dynamics
11.4.1 Paclitaxel Drug Industry Trends
11.4.2 Paclitaxel Drug Market Drivers
11.4.3 Paclitaxel Drug Market Challenges
11.4.4 Paclitaxel Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Paclitaxel Drug Distributors
12.3 Paclitaxel Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 30mg
Table 2. Major Company of 100mg
Table 3. Global Paclitaxel Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Paclitaxel Drug Sales by Type (2018-2024) & (K Units)
Table 5. Global Paclitaxel Drug Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Paclitaxel Drug Sales by Type (2018-2024) & (US& Million)
Table 7. Global Paclitaxel Drug Market Share in Value by Type (2018-2024)
Table 8. Global Paclitaxel Drug Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Paclitaxel Drug Sales by Type (2024-2029) & (K Units)
Table 10. Global Paclitaxel Drug Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Paclitaxel Drug Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Paclitaxel Drug Sales Market Share in Value by Type (2024-2029)
Table 13. Global Paclitaxel Drug Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Paclitaxel Drug Sales by Type (2018-2024) & (K Units)
Table 15. North America Paclitaxel Drug Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Paclitaxel Drug Sales (K Units) by Type (2018-2024)
Table 17. Europe Paclitaxel Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Paclitaxel Drug Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Paclitaxel Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Paclitaxel Drug Sales (K Units) by Type (2018-2024)
Table 21. Latin America Paclitaxel Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Paclitaxel Drug Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Paclitaxel Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Paclitaxel Drug Sales by Company (2018-2024) & (K Units)
Table 25. Global Paclitaxel Drug Sales Share by Company (2018-2024)
Table 26. Global Paclitaxel Drug Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Paclitaxel Drug Revenue Share by Company (2018-2024)
Table 28. Global Market Paclitaxel Drug Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Paclitaxel Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Paclitaxel Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Paclitaxel Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into Paclitaxel Drug Market
Table 33. Key Manufacturers Paclitaxel Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Paclitaxel Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Paclitaxel Drug Sales by Region (2018-2024) & (K Units)
Table 37. Global Paclitaxel Drug Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Paclitaxel Drug Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Paclitaxel Drug Sales Market Share in Value by Region (2018-2024)
Table 40. Global Paclitaxel Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Paclitaxel Drug Sales by Region (2024-2029) & (K Units)
Table 42. Global Paclitaxel Drug Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Paclitaxel Drug Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Paclitaxel Drug Sales Market Share in Value by Region (2024-2029)
Table 45. Global Paclitaxel Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Paclitaxel Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Paclitaxel Drug Sales by Application (2018-2024) & (K Units)
Table 48. Global Paclitaxel Drug Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Paclitaxel Drug Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Paclitaxel Drug Sales Market Share in Value by Application (2018-2024)
Table 51. Global Paclitaxel Drug Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Paclitaxel Drug Sales by Application (2024-2029) & (K Units)
Table 53. Global Paclitaxel Drug Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Paclitaxel Drug Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Paclitaxel Drug Sales Market Share in Value by Application (2024-2029)
Table 56. Global Paclitaxel Drug Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Paclitaxel Drug Sales by Application (2018-2024) (K Units)
Table 58. North America Paclitaxel Drug Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Paclitaxel Drug Sales by Application (2018-2024) (K Units)
Table 60. Europe Paclitaxel Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Paclitaxel Drug Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Paclitaxel Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Paclitaxel Drug Sales by Application (2018-2024) (K Units)
Table 64. Latin America Paclitaxel Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Paclitaxel Drug Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Paclitaxel Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Paclitaxel Drug Sales by Country (2018-2024) & (K Units)
Table 68. North America Paclitaxel Drug Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Paclitaxel Drug Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Paclitaxel Drug Sales Market Share in Value by Country (2018-2024)
Table 71. North America Paclitaxel Drug Sales by Country (2024-2029) & (K Units)
Table 72. North America Paclitaxel Drug Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Paclitaxel Drug Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Paclitaxel Drug Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Paclitaxel Drug Sales by Country (2018-2024) & (K Units)
Table 76. Europe Paclitaxel Drug Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Paclitaxel Drug Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Paclitaxel Drug Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Paclitaxel Drug Sales by Country (2024-2029) & (K Units)
Table 80. Europe Paclitaxel Drug Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Paclitaxel Drug Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Paclitaxel Drug Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Paclitaxel Drug Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Paclitaxel Drug Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Paclitaxel Drug Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Paclitaxel Drug Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Paclitaxel Drug Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Paclitaxel Drug Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Paclitaxel Drug Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Paclitaxel Drug Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Paclitaxel Drug Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Paclitaxel Drug Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Paclitaxel Drug Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Paclitaxel Drug Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Paclitaxel Drug Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Paclitaxel Drug Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Paclitaxel Drug Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Paclitaxel Drug Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Paclitaxel Drug Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Paclitaxel Drug Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Paclitaxel Drug Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Paclitaxel Drug Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Paclitaxel Drug Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Paclitaxel Drug Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Paclitaxel Drug Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Paclitaxel Drug Sales Market Share in Value by Country (2024-2029)
Table 107. Luye Pharma Company Information
Table 108. Luye Pharma Introduction and Business Overview
Table 109. Luye Pharma Paclitaxel Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Luye Pharma Paclitaxel Drug Product
Table 111. Luye Pharma Recent Development
Table 112. CSPC Company Company Information
Table 113. CSPC Company Introduction and Business Overview
Table 114. CSPC Company Paclitaxel Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. CSPC Company Paclitaxel Drug Product
Table 116. CSPC Company Recent Development
Table 117. Celgene Company Information
Table 118. Celgene Introduction and Business Overview
Table 119. Celgene Paclitaxel Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Celgene Paclitaxel Drug Product
Table 121. Celgene Recent Development
Table 122. Jiangsu Hengrui Company Information
Table 123. Jiangsu Hengrui Introduction and Business Overview
Table 124. Jiangsu Hengrui Paclitaxel Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Jiangsu Hengrui Paclitaxel Drug Product
Table 126. Jiangsu Hengrui Recent Development
Table 127. Bristol-Myers Squibb Company Information
Table 128. Bristol-Myers Squibb Introduction and Business Overview
Table 129. Bristol-Myers Squibb Paclitaxel Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Bristol-Myers Squibb Paclitaxel Drug Product
Table 131. Bristol-Myers Squibb Recent Development
Table 132. Pfizer Company Information
Table 133. Pfizer Introduction and Business Overview
Table 134. Pfizer Paclitaxel Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Pfizer Paclitaxel Drug Product
Table 136. Pfizer Recent Development
Table 137. Teva Company Information
Table 138. Teva Introduction and Business Overview
Table 139. Teva Paclitaxel Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Teva Paclitaxel Drug Product
Table 141. Teva Recent Development
Table 142. Mylan Company Information
Table 143. Mylan Introduction and Business Overview
Table 144. Mylan Paclitaxel Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Mylan Paclitaxel Drug Product
Table 146. Mylan Recent Development
Table 147. Novartis Company Information
Table 148. Novartis Introduction and Business Overview
Table 149. Novartis Paclitaxel Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Novartis Paclitaxel Drug Product
Table 151. Novartis Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Paclitaxel Drug Market Trends
Table 155. Paclitaxel Drug Market Drivers
Table 156. Paclitaxel Drug Market Challenges
Table 157. Paclitaxel Drug Market Restraints
Table 158. Paclitaxel Drug Distributors List
Table 159. Paclitaxel Drug Downstream Customers
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Paclitaxel Drug Product Picture
Figure 2. Global Paclitaxel Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Paclitaxel Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Paclitaxel Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 30mg
Figure 6. Global 30mg Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 100mg
Figure 8. Global 100mg Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Paclitaxel Drug Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Paclitaxel Drug Sales Market Share by Type in 2022 & 2029
Figure 11. North America Paclitaxel Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America Paclitaxel Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe Paclitaxel Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe Paclitaxel Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Paclitaxel Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Paclitaxel Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America Paclitaxel Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Paclitaxel Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Paclitaxel Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Paclitaxel Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Paclitaxel Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Paclitaxel Drug Revenue in 2022
Figure 23. Paclitaxel Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Drugs Store
Figure 27. Global Drugs Store Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Global Paclitaxel Drug Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Paclitaxel Drug Sales Market Share by Application in 2022 & 2029
Figure 30. North America Paclitaxel Drug Sales Market Share in Volume by Application in 2022
Figure 31. North America Paclitaxel Drug Sales Market Share in Value by Application in 2022
Figure 32. Europe Paclitaxel Drug Sales Market Share in Volume by Application in 2022
Figure 33. Europe Paclitaxel Drug Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Paclitaxel Drug Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Paclitaxel Drug Sales Market Share in Value by Application in 2022
Figure 36. Latin America Paclitaxel Drug Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Paclitaxel Drug Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Paclitaxel Drug Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Paclitaxel Drug Manufacturing Cost Structure
Figure 41. Paclitaxel Drug Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries